135 related articles for article (PubMed ID: 11786070)
1. Brain necrosis after enucleation, external beam cobalt radiotherapy, and systemic chemotherapy for retinoblastoma.
Padula GD; McCormick B; Abramson DH
Arch Ophthalmol; 2002 Jan; 120(1):98-9. PubMed ID: 11786070
[No Abstract] [Full Text] [Related]
2. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
[TBL] [Abstract][Full Text] [Related]
3. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
4. Management of massive orbital involvement of intraocular retinoblastoma.
Kiratli H; Bilgiç S; Ozerdem U
Ophthalmology; 1998 Feb; 105(2):322-6. PubMed ID: 9479294
[TBL] [Abstract][Full Text] [Related]
5. Late ocular recurrence of retinoblastoma after external radiation.
Daoud A; Raymond LA; Lampkin BC; Spaulding A; Poon J
J Pediatr Ophthalmol Strabismus; 1978; 15(5):282-5. PubMed ID: 24877413
[No Abstract] [Full Text] [Related]
6. Orbital retinoblastoma: case report.
Mabtum ED; Bonanomi MT; Lima PP; Almeida MT
Arq Bras Oftalmol; 2013; 76(4):247-9. PubMed ID: 24061839
[TBL] [Abstract][Full Text] [Related]
7. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
8. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
9. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
10. Intraocular surgery after treatment of germline retinoblastoma.
Moshfeghi DM; Wilson MW; Grizzard S; Haik BG
Arch Ophthalmol; 2005 Jul; 123(7):1008-12. PubMed ID: 16009848
[No Abstract] [Full Text] [Related]
11. Rhegmatogenous retinal detachment in retinoblastoma patients undergoing chemoreduction and cryotherapy.
Anagnoste SR; Scott IU; Murray TG; Kramer D; Toledano S
Am J Ophthalmol; 2000 Jun; 129(6):817-9. PubMed ID: 10927003
[TBL] [Abstract][Full Text] [Related]
12. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
13. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
14. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
[TBL] [Abstract][Full Text] [Related]
15. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
[TBL] [Abstract][Full Text] [Related]
16. Managing the consequences of aggressive conservative treatment for refractory retinoblastoma with vitreous seeding.
Brink A; Correa ZM; Geller J; Abruzzo T; Augsburger JJ
Arq Bras Oftalmol; 2014 Aug; 77(4):256-8. PubMed ID: 25410179
[TBL] [Abstract][Full Text] [Related]
17. [Available approaches to retinoblastoma therapy--literature review].
Morawski K; Kulig-Stochmal A; Drychowska-Jęmhorska JJ; Kuhicka-Trząska A; Romanowska-Dixon B
Klin Oczna; 2015; 117(1):45-9. PubMed ID: 26349159
[TBL] [Abstract][Full Text] [Related]
18. Management of advanced retinoblastoma.
Honavar SG; Singh AD
Ophthalmol Clin North Am; 2005 Mar; 18(1):65-73, viii. PubMed ID: 15763192
[TBL] [Abstract][Full Text] [Related]
19. NEWLY DIAGNOSED ACTIVE RETINOBLASTOMA IN ADULTS.
Kaliki S; Shields CL; Gupta A; Mishra DK; Das C; Say EA; Shields JA
Retina; 2015 Dec; 35(12):2483-8. PubMed ID: 26035399
[TBL] [Abstract][Full Text] [Related]
20. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
